Depletion of butyrate-producing microbes of the Firmicutes predicts nonresponse to FMT therapy in patients with recurrent Clostridium difficile infection
ABSTRACTApproximately 10% of individuals diagnosed with Clostridium difficile infection (CDI) show the resistance to fecal microbiota transplantation (FMT), with the underlying mechanisms remaining elusive. Deciphering the intricate microbiome profile within this particular subset of FMT-refractory...
Main Authors: | Hongliang Tian, Jiaqu Cui, Chen Ye, Jiangman Zhao, Bo Yang, Yue Xu, Shushen Ji, Le Wang, Xiaoqiong Lv, Chunlian Ma, Shailan Zhou, Ning Li, Xinjun Wang, Huanlong Qin, Qiyi Chen |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2023-12-01
|
Series: | Gut Microbes |
Subjects: | |
Online Access: | https://www.tandfonline.com/doi/10.1080/19490976.2023.2236362 |
Similar Items
-
Applying fecal microbiota transplantation (FMT) to treat recurrent Clostridium difficile infections (rCDI) in children
by: Shaaz Fareed, et al.
Published: (2018-05-01) -
Clostridium difficile – From Colonization to Infection
by: Holger Schäffler, et al.
Published: (2018-04-01) -
Clostridium difficile Causing Empyema
by: Abdalla Mohamed, et al.
Published: (2018-10-01) -
Butyrate Protects against Clostridium difficile Infection by Regulating Bile Acid Metabolism
by: Siqi Wang, et al.
Published: (2023-08-01) -
Mortality and <it>Clostridium difficile</it> infection: a review
by: Mitchell Brett G, et al.
Published: (2012-05-01)